161
Shang L#, Gu X#, Du S, Wang Y, Cao B*, Wang C*, for CAP-China Network. The efficacy and safety of therapeutic lung lavage for exogenous lipoid pneumonia: A systematic review. Clin Respir J. 2021 Feb;15(2):134-146. doi: 10.1111/crj.13273. Epub 2021 Feb 2.
162
Huang L#, Gu X, Wang Y, Huang C, Bin Cao B*. Long-term effects of COVID-19 on kidney function - Authors' reply. Lancet. 2021 May 15;397(10287):1807-1808. doi: 10.1016/S0140-6736(21)00875-8.
163
Huang C#, Huang L#, Wang Y#, Li X#, Ren L#, Gu X#, Kang L#, Guo L#, Liu M#, Zhou X, Luo J, Huang Z, Tu S, Zhao, Y, Chen L, Xu D, Li Y, L C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan g, Xu J, Wang G, Wang Y, Zhang J, Wang C, Wang J*, Zhang D*, Cao B*. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 Jan 16;397(10270):220-232; doi: 10.1016/S0140-6736(20)32656-8
164
Zhao J#, Zhang Y, Fan Y, Han J, Xiong Z, Liu X, Li B, Lu B*, Cao B*. Characterization of an NDM-5-producing hypervirulent Klebsiella pneumoniae sequence type 65 clone from a lung transplant recipient. Emerg Microbes Infect. 2021 Dec;10(1):396-399. doi: 10.1080/22221751.2021.1889932.
165
Han X#, Chen L, Wang Y, Li H, Wang H, Xing X, Zhang C, Suo L, Wang J, Yu G, Wang G, Yao X, Yu H, Wang L, Liu X*, Cao B*, CAP-China Network. Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward. Infect Drug Resist. 2021 May 18;14:1845-1853. doi: 10.2147/IDR.S302852. eCollection 2021.
166
Huang L#,Cao B*. Post-acute conditions of patients with COVID-19 not requiring hospital admission. Lancet Infect Dis. 2021 May 10;S1473-3099(21)00225-5. doi: 10.1016/S1473-3099(21)00225-5. Online ahead of print.
167
Shang L#, David Chien Lye,Cao B*. Contemporary narrative review of treatment options for COVID-19. Respirology. 2021 Aug;26(8):745-767. doi: 10.1111/resp.14106. Epub 2021 Jul 8.
168
Gu X, Cao B. In-hospital complications associated with COVID-19. Lancet. 2021 Jul 17;398(10296):188-190. doi: 10.1016/S0140-6736(21)00983-1.
169
Xu J#, Cao B*. Letter from China: Managing the second-wave COVID-19 outbreak in Beijing. Respirology. 2021 Jan 5. doi: 10.1111/resp.14002. Online ahead of print.
170
Liu S#, Huang Z#, Deng X, Zou X, Li H, Mu S, Cao B*. Identification of key candidate biomarkers for severe influenza infection by integrated bioinformatical analysis and initial clinical validation. J Cell Mol Med. 2021 Jan 14. doi: 10.1111/jcmm.16275. Online ahead of print.
171
Li H#, Gu X#, Li H#, Gong F#, Xu J, Wang Y, Li H, Ruan S, Yang Q, Cao B*. Risk factors of viral RNAaemia and its association with clinical prognosis among patients with severe COVID-19. Chest. 2021 Jan 6;S0012-3692(21)00007-6. doi: 10.1016/j.chest.2020.11.071.
173
李丽娟﹟,黎斌斌,王一民,王春雷,孙凌霄,刘颖梅,鲁炳怀,曹彬*.成人副流感病毒下呼吸道感染患者临床特征和预后分析[J].中华医学杂志,2020,100(27):2109-2115.
175
李丽娟﹟,刘思危,孙凌霄,王一民,刘颖梅,王金祥,任亚莉,刘波,潘建亮,刘菲菲,宋丽斯,王传,曹彬*.成人鼻病毒肺炎临床特征和混合感染病原学特点分析[J].中国呼吸与危重监护杂志,2020,19(05):451-456.
